FDA Issued Warning Over Unapproved Botulinum Toxin
Federal regulators cautioned consumers against using unverified cosmetic injectables found on two websites.
Updated on Sept. 29, 2026 in Beauty
Live Poll
Do you trust that online retailers provide enough safety oversight for the medical products they sell?
On September 14, 2026, the FDA issued a warning letter to Celmade regarding the sale of unapproved and misbranded botulinum toxin products, such as Wondertox. These products were marketed to consumers in the United States for facial muscle relaxation and hyperhidrosis relief.
Why it matters
Unapproved injectable drugs bypass the safety evaluations required by the FDA, posing significant health risks to the public including potential life-threatening conditions like sepsis. These products have not been recognized as safe or effective for their intended uses.
The FDA warning followed evaluations of www.celmade.co on August 4, 2026, and celmade.net on September 1, 2026. Reviewers determined the botulinum toxin products sold by these sites were misbranded, as they lacked the approved applications and adequate directions for use required.
The players
FDA
The federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs and medical devices.
Celmade
The entity identified by federal regulators for marketing and distributing unapproved and misbranded botulinum toxin products directly to consumers.
The details
Botulinum toxin is a potent substance that requires rigorous testing to ensure its concentration and purity when used in medical or cosmetic procedures. The products identified by the FDA, including Wonder tox 100, were introduced into interstate commerce without the mandated oversight to verify their safety. Injecting substances of unknown origin bypasses the body's natural defenses, creating a risk for severe bacterial infections or other adverse systemic reactions.
Timeline
August 4, 2026: FDA reviewed the website www.celmade.co.
September 1, 2026: FDA reviewed the website celmade.net.
September 14, 2026: The FDA issued the warning letter to Celmade.
Health Landscape
This enforcement action highlights the ongoing regulatory effort to curb the sale of unapproved medical products marketed online. It underscores the critical difference between vetted cosmetic procedures and unverified products that bypass established safety and efficacy standards.
If you are considering cosmetic injectables, always verify that your provider is using products approved by the FDA for your specific treatment. It is worth discussing the source and safety profile of any injectable medication with your physician or a board-certified dermatologist.
The takeaway
When it comes to injectable treatments, the source of the product is as critical as the skill of the person administering it. If a deal for cosmetic injectables seems too good to be true or is available through unverified online retailers, avoid it and prioritize safety by consulting a doctor.
What happens next
Celmade is required to submit a written response to the FDA within 15 business days of receiving the letter. Failure to address the identified violations may lead to further regulatory or legal action, such as seizure of products or an injunction.
Further reading
For more on the risks of unauthorized aesthetic treatments, visit our Beauty section.
Source note: This article includes information reported by U.S. Food and Drug Administration.
Live Poll
Do you trust that online retailers provide enough safety oversight for the medical products they sell?
